Abstract
The formation of deoxyribonucleic acid (DNA) adducts can have important and adverse consequences for cellular and whole organism function. Available methods for identification of DNA damage and quantification of adducts are reviewed. Analyses can be performed on various samples including tissues, isolated cells, and intact or hydrolyzed (digested) DNA from a variety of biological samples of interest for monitoring in humans. Sensitivity and specificity are considered key factors for selecting the type of method for assessing DNA perturbation. The amount of DNA needed for analysis is dependent upon the method and ranges widely, from <1 μg to 3 mg. The methods discussed include the Comet assay, the ligation-mediated polymerase reaction, histochemical and immunologic methods, radiolabeled (14C- and 3H-) binding, 32P-postlabeling, and methods dependent on gas chromatography (GC) or high-performance liquid chromatography (HPLC) with detection by electron capture, electrochemical detection, single or tandem mass spectrometry, or accelerator mass spectrometry. Sensitivity is ranked, and ranges from ∼1 adduct in 104 to 1012 nucleotides. A brief overview of oxidatively generated DNA damage is also presented. Assay limitations are discussed along with issues that may have impact on the reliability of results, such as sample collection, processing, and storage. Although certain methodologies are mature, improving technology will continue to enhance the specificity and sensitivity of adduct analysis. Because limited guidance and recommendations exist for adduct analysis, this effort supports the HESI Committee goal of developing a framework for use of DNA adduct data in risk assessment.
Acknowledgements
The authors thank the ILSI HESI staff, especially Dr. Michelle Embry and Ms. Syril Petit, for administrative and technical support. Valuable discussions with Dr. Lynn Pottenger, the authors of the companion framework report, and Dr. G. Don Jones are greatly appreciated.
Disclaimer: This document represents the consensus of the participants’ views expressed as individual scientists and does not necessarily represent the policies and procedures of their respective institutions.
Declaration of interest: The author have no commercial conflict of interest to declare. This publication stems from a subgroup of the HESI Biological Significance of DNA Adducts Project Committee, whose work is funded through ILSI/HESI.
Abbreviations
2D TLC two-dimensional thin-layer chromatography
3-MeAde 3-methyladenine
8-oxoGua 8-oxo-7,8-dihydroguanine
8-oxodGuo 8-oxo-7,8-dihydro-2’-deoxyguanosine
AMS accelerator mass spectrometry
B[a]P benzo[a]pyrene
14C carbon-14
CO2 carbon dioxide
DNA deoxyribonucleic acid
DMSO dimethyl sulfoxide
EC electrochemical detection
ECD electron capture detection
ELISA enzyme-linked immunosorbent assay
Endo III endonuclease III
ESCODD European Standards Committee on Oxidative DNA Damage
FL fluorescence detection
Fpg formamidopyrimidine-DNA glycosylase
GC gas chromatography
GC-ECD gas chromatography-electron capture detection
GC-MS gas chromatography mass spectrometry
3H tritium
hOGG1 human 8-oxoguanine-DNA glycosylase
HPLC high-performance liquid chromatography
HPLC-EC HPLC–electrochemical detection
ISB immunoslot blot
LC-MS/MS liquid chromatography-tandem mass spectrometry
LC-NMR liquid chromatography-nuclear magnetic resonance
LM-PCR ligation-mediated polymerase chain reaction
M1-dG malondialdehyde-2′-deoxyguanosine
MRM multiple reaction monitoring
MS mass spectrometry
MS/MS tandem mass spectrometry
NMR nuclear magnetic resonance
PAH polycyclic aromatic hydrocarbons
PCR polymerase chain reaction
32P-ATP phosphorus–32 adenosine triphosphate
RIA radioimmunoassay
RNA ribonucleic acid
SIM selected ion monitoring
SRM selected reaction monitoring
TLC thin-layer chromatography
UV ultraviolet